These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 8847537)
21. Pramipexole and ropinirole for Parkinson's disease. Med Lett Drugs Ther; 1997 Nov; 39(1014):109-10. PubMed ID: 9398824 [No Abstract] [Full Text] [Related]
22. The challenge of managing mild Parkinson's disease. LeWitt PA Pharmacotherapy; 2000 Jan; 20(1 Pt 2):2S-7S. PubMed ID: 10641986 [TBL] [Abstract][Full Text] [Related]
23. Clinical practice. Diagnosis and initial management of Parkinson's disease. Nutt JG; Wooten GF N Engl J Med; 2005 Sep; 353(10):1021-7. PubMed ID: 16148287 [No Abstract] [Full Text] [Related]
24. Guideline for the treatment of Parkinson's disease. Carr J; Kies B; Fine J; S Afr Med J; 2009 Oct; 99(10):755-6, 758. PubMed ID: 20128276 [No Abstract] [Full Text] [Related]
26. Pergolide in Parkinson's disease: time for a change? Grosset KA; Grosset DG Lancet; 2004 Jun; 363(9424):1907-8. PubMed ID: 15183636 [No Abstract] [Full Text] [Related]
27. Parkinson's disease. Clarke C; Moore AP Clin Evid; 2002 Jun; (7):1208-20. PubMed ID: 12230738 [No Abstract] [Full Text] [Related]
28. Clinical inquiries. What is the best initial treatment of Parkinson's disease? Schreck J; Kelsberg G; Rich J; Ward R J Fam Pract; 2003 Nov; 52(11):897-9. PubMed ID: 14599387 [No Abstract] [Full Text] [Related]
29. Dopamine neurotransmission and treatments for Parkinson's disease in the molecular biology era. Ogawa N Eur Neurol; 1997; 38 Suppl 1():2-5. PubMed ID: 9276193 [TBL] [Abstract][Full Text] [Related]
30. [The role of dopaminagonists in the treatment of Parkinson's disease]. Ransmayr G Praxis (Bern 1994); 2005 Oct; 94(42):1633-8. PubMed ID: 16277084 [TBL] [Abstract][Full Text] [Related]
31. Parkinson's disease. Clarke C; Moore AP Clin Evid; 2003 Dec; (10):1582-98. PubMed ID: 15555162 [No Abstract] [Full Text] [Related]
33. [Use of dopamine agonists in the treatment of Parkinson's disease]. Gekht AB Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(9):54-8. PubMed ID: 12378886 [No Abstract] [Full Text] [Related]
35. Effective strategies in the management of Parkinson's disease. Wills AJ Hosp Med; 1998 Apr; 59(4):287-90. PubMed ID: 9722367 [TBL] [Abstract][Full Text] [Related]
36. The variability of levodopa response in Parkinson's disease: is sensitization reversible? Jabre MG; Bejjani BP Mov Disord; 2008 Apr; 23(6):924; author reply 925. PubMed ID: 18163452 [No Abstract] [Full Text] [Related]
37. [Prevalence and main methods of treatment of advanced stages of Parkinson's disease]. Seliverstov IuA; Illarioshkin SN Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(11):100-6. PubMed ID: 24479164 [No Abstract] [Full Text] [Related]
38. Hallmarks of Treatment Aspects: Parkinson's Disease Throughout Centuries Including l-Dopa. Kim HJ; Jeon BS; Jenner P Int Rev Neurobiol; 2017; 132():295-343. PubMed ID: 28554412 [TBL] [Abstract][Full Text] [Related]
39. Parkinson's disease. Clarke C; Moore A Clin Evid; 2002 Dec; (8):1370-85. PubMed ID: 12603943 [No Abstract] [Full Text] [Related]